Perrigo Company plc
HealthcareNYSE:PRGO · New York Stock Exchange
+$0.09 today
Vol 2.50M · Avg 3.05M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $357.2M |
| Receivables | $732.8M |
| Inventory | $1.1B |
| Other Current | $501.0M |
| Total Current Assets | $2.7B |
| PP&E (Net) | $1.0B |
| Goodwill | $1.7B |
| Intangible Assets | $2.3B |
| Long-term Investments | $27.2M |
| Tax Assets | $4.7M |
| Other Non-current | $233.3M |
| Total Non-current Assets | $5.3B |
| Total Assets | $8.0B |
Analysis
Selected assets total $8.0B for Latest. The largest visible component is Intangible Assets at $2.3B, about 28.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $531.6M -4.9% | $558.8M -25.6% | $751.3M +25.1% | $600.7M -67.8% | $1.9B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $612.8M -4.6% | $642.3M -13.2% | $739.6M +6.1% | $697.1M +6.8% | $652.9M | $533.8M | $399.4M | -$1.7B |
| Inventory | $1.1B +6.2% | $1.1B -5.2% | $1.1B -0.8% | $1.2B +12.8% | $1.0B | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $504.0M +153.3% | $199.0M -1.0% | $201.1M -26.0% | $271.8M +1588.2% | $16.1M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $2.8B +12.7% | $2.5B -12.4% | $2.8B +4.2% | $2.7B -29.5% | $3.9B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $1.1B -2.4% | $1.1B -0.6% | $1.1B -3.8% | $1.1B +10.9% | $1.0B | $1.2B | $1.5B | $687.8M |
| Goodwill | $2.1B -38.3% | $3.3B -5.9% | $3.5B +1.1% | $3.5B +16.4% | $3.0B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $2.4B -3.2% | $2.4B -18.7% | $3.0B -9.2% | $3.3B +52.9% | $2.2B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $25.4M | $0 | $0 | $0 | $0 | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $3.3M -35.3% | $5.1M -80.2% | $25.8M +263.4% | $7.1M +9.2% | $6.5M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $236.4M -25.8% | $318.6M -5.0% | $335.2M -8.8% | $367.7M -2.6% | $377.5M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $5.7B -19.9% | $7.2B -10.2% | $8.0B -3.9% | $8.3B +26.4% | $6.6B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $8.5B -11.5% | $9.6B -10.7% | $10.8B -1.9% | $11.0B +5.7% | $10.4B | $13.3B | $11.9B | $10.6B |
| Account Payables | $474.5M -4.2% | $495.2M +3.7% | $477.7M -11.1% | $537.3M +30.7% | $411.2M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $62.3M +71.2% | $36.4M -91.7% | $440.6M +1117.1% | $36.2M -94.0% | $603.8M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $20.8M +19.5% | $17.4M -58.7% | $42.1M +192.4% | $14.4M -12.7% | $16.5M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $343.1M | $0 | $0 +100.0% | -$28.4M -157.8% | $49.1M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $1.0B -3.0% | $1.0B -34.2% | $1.6B +42.4% | $1.1B -29.9% | $1.6B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $3.7B +4.5% | $3.6B -1.4% | $3.6B -10.8% | $4.1B +39.6% | $2.9B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $168.9M -16.9% | $203.2M -22.5% | $262.3M -28.8% | $368.2M +53.9% | $239.3M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $511.3M +2.4% | $499.2M -10.8% | $559.8M +29.1% | $433.5M +13.2% | $382.8M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $4.6B +7.1% | $4.3B -3.8% | $4.5B -12.0% | $5.1B +37.3% | $3.7B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $5.6B +5.1% | $5.3B -11.8% | $6.0B -2.2% | $6.2B +17.1% | $5.3B | $14.7B | $3.7B | $9.6B |
| Common Stock | $6.6B -1.9% | $6.7B -1.5% | $6.8B -1.4% | $6.9B -1.5% | $7.0B | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$3.7B -63.3% | -$2.3B -8.3% | -$2.1B -0.6% | -$2.1B -7.3% | -$1.9B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $14.1M +108.7% | -$162.4M -1617.8% | $10.7M +139.6% | -$27.0M -176.1% | $35.5M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | -$9.3M | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $2.9B -32.0% | $4.3B -9.4% | $4.8B -1.5% | $4.8B -6.0% | $5.2B | $9.1B | $7.7B | $3.3B |
| Total Debt | $4.0B +9.7% | $3.6B -11.2% | $4.1B -5.8% | $4.3B +17.1% | $3.7B | $724.2M | $410.6M | $399.4M |
| Net Debt | $3.4B +12.4% | $3.1B -7.9% | $3.3B -10.8% | $3.7B +103.6% | $1.8B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.29B
Amicus Therapeutics, Inc.
FOLD
$4.55B
LivaNova PLC
NASDAQ:LIVN
$4.36B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.87B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.67B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.58B
Surgery Partners, Inc.
NASDAQ:SGRY
$2.00B
HUTCHMED (China) Limited
NASDAQ:HCM
$1.91B
Bausch Health Companies Inc.
NYSE:BHC
$1.89B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.27B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does PRGO have?
Perrigo Company plc (PRGO) reported $531.60M in cash and equivalents in fiscal 2025.
How much debt does PRGO carry?
Perrigo Company plc (PRGO) reported $3.97B of total debt, with net debt of $3.44B.
Explore More
Continue the stock analysis
Jump to another research area for this company.